ARSENAULT KAITLYN (Chief Financial Officer) sold 20.7% of their position (43.40K shares) of SKYE BIOSCIENCE, INC. on the open market
Open‑market sale worth $216.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/19/2024ACC: 0001516551-24-000117
Officer· Chief Financial Officer
Since Oct 2021
-43.40K
Net shares
Net seller
$216.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
43.40K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−190.00
Price / share
$5.55
Trade value
$1.05K
% of position
0.1%
11/15/2024
209.74K→209.55K
Common Stock
Direct
Shares
−43.21K
Price / share
$4.99
Trade value
$215.60K
% of position
20.6%
11/18/2024
209.55K→166.34K
Total
Net shares
−43.40K
Net value
-$216.65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2024 | S · Sale | −190.00 | $5.55 | $1.05K | 0.1% | 209.74K | 209.55K |
| Common Stock Direct | 11/18/2024 | S · Sale | −43.21K | $4.99 | $215.60K | 20.6% | 209.55K | 166.34K |
| Total | −43.40K | -$216.65K | ||||||
Derivative Transactions0
No derivative transactions reported